Skip to main
  1. Stocks
  2. Spectral AI Inc
  3. Forecast
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is viewed positively because FDA clearance for the DeepView System materially de-risks a platform that has been in development and clinical investigation for numerous years, while also setting up a commercial launch in 2H26. The investment case is strengthened by BARDA support, including ~$31.7M of funding in March 2026, planned distribution of ~30 systems, and potential subsidy for an additional ~140 systems, which should aid early adoption and reduce execution risk. With a targeted U.S. addressable market of ~125 Burn Centers and ~5,000 Trauma and ED units, plus FY26 revenue guidance of $18.5M and a modeled 110% CAGR in FY26 through FY30, the company offers a high-upside growth profile in a large, under-penetrated medtech niche.

Bears say

Spectral AI is viewed negatively because its revenue outlook is highly exposed to clinical and regulatory delays, which could reduce BARDA-related revenue and push out commercialization. The company also faces meaningful execution risk from setbacks in approvals that could require additional analysis, filings, or more clinical data, while adoption of the DeepView system in a commercial setting may remain limited. More broadly, limited technology awareness, a short operating history, competition, limited reimbursement, cybersecurity risk, and the potential need for additional capital all weaken the fundamental risk-reward profile.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

MDAI Analyst Forecast & Price Prediction

Get the latest MDAI stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MDAI

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Nov 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


MDAI Analyst Forecast & Price Prediction

Get the latest MDAI stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MDAI

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MDAI stock data and trends